Exosome RNA Exosome RNA Research & Industry News
PODs Will Support Clinical Manufacturing for this Novel Therapeutic Modality.
G-CON Manufacturing, the leader in prefabricated, flexible cleanroom solutions, announced today that it has been selected by Codiak BioSciences to support its cleanroom build out at its new clinical manufacturing facility in Lexington, MA. The PODs will provide the cleanroom infrastructure for the drug substance and product manufacturing for its clinical pipeline.
Codiak chose PODs to streamline the buildout of the facility; the cleanroom infrastructures are being built in parallel with the site retrofitting to shorten the overall project timeline. The prefabricated autonomous PODs will allow for easy expansion in the same facility when additional capacity is needed to support Codiak’s growing pipeline.
“Exosomes are often talked about as being the next revolutionary modality in our industry, likely to follow the cell and gene therapy movement that we are experiencing,” stated Peter Makowenskyj, Director of Sales Engineering at G-CON. “It is very exciting to work with a pioneer in this space, helping Codiak to build out their infrastructure and helping them to keep the manufacturing and development know how in house.”
“Building a scalable, high-performance exosome manufacturing process has been a priority of Codiak since our inception,” said Konstantin Konstantinov, Executive Vice President, Manufacturing and Process Sciences at Codiak BioSciences. “Our new Clinical Manufacturing Facility is a critical part of this strategy, and we were pleased to work with G-CON in building the infrastructure to produce our engineered exosomes at the quality and quantities needed to support the future growth of our programs.”
Source – PRWeb
